Search Browse Earnings

BIOHARVEST SCIENCES INC. — SlamSEC

BIOHARVEST SCIENCES INC.

Nasdaq:BHST

Pharmaceutical Preparations·VANCOUVER, A1

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$12.7M

FY 2024

Adj. EBITDA

-$9.1M

-72.0% margin

FY 2024

Net Income

-$12.6M

-99.1% margin

FY 2024

EPS (Diluted)

-$0.93

FY 2024

Stock Price

$4.22

+1.7%

2026-03-06

52W Range

$4.10 – $12.80

P/E Ratio

-4.5x

Market Cap

$73.1M

Cash

$5.4M

FY 2024

Total Debt

—

Net Cash

$5.4M

FY 2024

Enterprise Value

$67.8M

Debt / EBITDA

0.6x

FY 2024

EV / EBITDA

-7.4x

Employees

—